keyword
https://read.qxmd.com/read/38726013/evaluation-of-the-immunogenicity-of-an-mrna-vectored-nipah-virus-vaccine-candidate-in-pigs
#21
JOURNAL ARTICLE
Miriam Pedrera, Rebecca K McLean, Lobna Medfai, Nazia Thakur, Shawn Todd, Glenn Marsh, Dalan Bailey, Gaetano Donofrio, Hiromi Muramatsu, Norbert Pardi, Drew Weissman, Simon P Graham
Nipah virus (NiV) poses a significant threat to human and livestock populations across South and Southeast Asia. Vaccines are required to reduce the risk and impact of spillover infection events. Pigs can act as an intermediate amplifying host for NiV and, separately, provide a preclinical model for evaluating human vaccine candidate immunogenicity. The aim of this study was therefore to evaluate the immunogenicity of an mRNA vectored NiV vaccine candidate in pigs. Pigs were immunized twice with 100 μg nucleoside-modified mRNA vaccine encoding soluble G glycoprotein from the Malaysia strain of NiV, formulated in lipid nanoparticles...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38726007/comparative-single-cell-multiplex-immunophenotyping-of-therapy-naive-patients-with-rheumatoid-arthritis-systemic-sclerosis-and-systemic-lupus-erythematosus-shed-light-on-disease-specific-composition-of-the-peripheral-immune-system
#22
COMPARATIVE STUDY
József Á Balog, Ágnes Zvara, Vivien Bukovinszki, László G Puskás, Attila Balog, Gábor J Szebeni
INTRODUCTION: Systemic autoimmune diseases (SADs) are a significant burden on the healthcare system. Understanding the complexity of the peripheral immunophenotype in SADs may facilitate the differential diagnosis and identification of potential therapeutic targets. METHODS: Single-cell mass cytometric immunophenotyping was performed on peripheral blood mononuclear cells (PBMCs) from healthy controls (HCs) and therapy-naive patients with rheumatoid arthritis (RA), progressive systemic sclerosis (SSc), and systemic lupus erythematosus (SLE)...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38726002/to-develop-a-prognostic-model-for-neoadjuvant-immunochemotherapy-efficacy-in-esophageal-squamous-cell-carcinoma-by-analyzing-the-immune-microenvironment
#23
JOURNAL ARTICLE
Zhou Yehan, Qin Sheng, Yang Hong, Li Jiayu, Hou Jun, Ji Juan, Shi Min, Yan Jiaxin, Hu Shangzhi, Wang Yi, Wang Qifeng, Leng Xuefeng, He Wenwu, Cheng Xueyan, Liu Yang, Huang Zongyao
OBJECTIVE: The choice of neoadjuvant therapy for esophageal squamous cell carcinoma (ESCC) is controversial. This study aims to provide a basis for clinical treatment selection by establishing a predictive model for the efficacy of neoadjuvant immunochemotherapy (NICT). METHODS: A retrospective analysis of 30 patients was conducted, divided into Response and Non-response groups based on whether they achieved major pathological remission (MPR). Differences in genes and immune microenvironment between the two groups were analyzed through next-generation sequencing (NGS) and multiplex immunofluorescence (mIF)...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38725676/th17-cell-and-inflammatory-infiltrate-interactions-in-cutaneous-leishmaniasis-unraveling-immunopathogenic-mechanisms
#24
REVIEW
Abraham U Morales-Primo, Ingeborg Becker, Claudia Patricia Pedraza-Zamora, Jaime Zamora-Chimal
The inflammatory response during cutaneous leishmaniasis (CL) involves immune and non-immune cell cooperation to contain and eliminate Leishmania parasites. The orchestration of these responses is coordinated primarily by CD4+ T cells; however, the disease outcome depends on the Th cell predominant phenotype. Although Th1 and Th2 phenotypes are the most addressed as steers for the resolution or perpetuation of the disease, Th17 cell activities, especially IL-17 release, are recognized to be vital during CL development...
April 2024: Immune Network
https://read.qxmd.com/read/38725670/immune-cells-are-differentially-affected-by-sars-cov-2-viral-loads-in-k18-hace2-mice
#25
JOURNAL ARTICLE
Jung Ah Kim, Sung-Hee Kim, Jeong Jin Kim, Hyuna Noh, Su-Bin Lee, Haengdueng Jeong, Jiseon Kim, Donghun Jeon, Jung Seon Seo, Dain On, Suhyeon Yoon, Sang Gyu Lee, Youn Woo Lee, Hui Jeong Jang, In Ho Park, Jooyeon Oh, Sang-Hyuk Seok, Yu Jin Lee, Seung-Min Hong, Se-Hee An, Joon-Yong Bae, Jung-Ah Choi, Seo Yeon Kim, Young Been Kim, Ji-Yeon Hwang, Hyo-Jung Lee, Hong Bin Kim, Dae Gwin Jeong, Daesub Song, Manki Song, Man-Seong Park, Kang-Seuk Choi, Jun Won Park, Jun-Won Yun, Jeon-Soo Shin, Ho-Young Lee, Ho-Keun Kwon, Jun-Young Seo, Ki Taek Nam, Heon Yung Gee, Je Kyung Seong
Viral load and the duration of viral shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are important determinants of the transmission of coronavirus disease 2019. In this study, we examined the effects of viral doses on the lung and spleen of K18-hACE2 transgenic mice by temporal histological and transcriptional analyses. Approximately, 1×105 plaque-forming units (PFU) of SARS-CoV-2 induced strong host responses in the lungs from 2 days post inoculation (dpi) which did not recover until the mice died, whereas responses to the virus were obvious at 5 days, recovering to the basal state by 14 dpi at 1×102 PFU...
April 2024: Immune Network
https://read.qxmd.com/read/38725219/bet-inhibition-sensitizes-innate-checkpoint-inhibitor-resistant-melanoma-to-anti-ctla-4-treatment
#26
JOURNAL ARTICLE
Hsin-Yi Tseng, Sara Alavi, Stuart Gallagher, Helen M McGuire, Peter Hersey, Abdullah Al Emran, Jessamy Tiffen
Approximately 50% of melanoma patients fail to respond to immune checkpoint blockade (ICB), and acquired resistance hampers long-term survival in about half of initially responding patients. Whether targeting BET reader proteins, implicated in epigenetic dysregulation, can enhance ICB response rates and durability, remains to be determined. Here we show elevated BET proteins correlate with poor survival and ICB responses in melanoma patients. The BET inhibitor IBET151, combined with anti-CTLA-4, overcame innate ICB resistance however, sequential BET inhibition failed against acquired resistance in mouse models...
May 9, 2024: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38725218/deciphering-cd4-t-cell-mediated-responses-against-cancer
#27
REVIEW
Catherine Kirkpatrick, Yong-Chen William Lu
It's been long thought that CD8+ cytotoxic T cells play a major role in T cell-mediated antitumor responses, whereas CD4+ T cells merely provide some assistance to CD8+ T cells as the "helpers." In recent years, numerous studies support the notion that CD4+ T cells play an indispensable role in antitumor responses. Here, we summarize and discuss the current knowledge regarding the roles of CD4+ T cells in antitumor responses and immunotherapy, with a focus on the molecular and cellular mechanisms behind these observations...
May 9, 2024: Molecular Carcinogenesis
https://read.qxmd.com/read/38725070/nk-cell-transfer-overcomes-resistance-to-pd-l-1-therapy-in-aged-mice
#28
JOURNAL ARTICLE
Junlei Hou, Shuanglong Xie, Jianbao Gao, Tao Jiang, Enjian Zhu, Xuezhi Yang, Zheng Jin, Haixia Long, Anmei Zhang, Fei Yang, Lujing Wang, Haoran Zha, Qingzhu Jia, Bo Zhu, Xinxin Wang
BACKGROUND: Cancer is the leading cause of death among older adults. Although the integration of immunotherapy has revolutionized the therapeutic landscape of cancer, the complex interactions between age and immunotherapy efficacy remain incompletely defined. Here, we aimed to elucidate the relationship between aging and immunotherapy resistance. METHODS: Flow cytometry was performed to evaluate the infiltration of immune cells in the tumor microenvironment (TME)...
May 9, 2024: Experimental Hematology & Oncology
https://read.qxmd.com/read/38725005/mettl14-regulates-cd8-t-cell-activation-and-immune-responses-to-anti-pd-1-therapy-in-lung-cancer
#29
JOURNAL ARTICLE
Chongqi Sun, Jian Wang, Huixing Li, Luyao Liu, Yu Lin, Ling Zhang, Xianglong Zu, Yizhi Zhu, Yongqian Shu, Dong Shen, Qiong Wang, Yiqian Liu
BACKGROUND: N6-methyladenosine (m6A) modification plays an important role in lung cancer. However, methyltransferase-like 14 (METTL14), which serves as the main component of the m6A complex, has been less reported to be involved in the immune microenvironment of lung cancer. This study aimed to analyze the relationship between METTL14 and the immune checkpoint inhibitor programmed death receptor 1 (PD-1) in lung cancer. METHODS: CCK-8, colony formation, transwell, wound healing, and flow cytometry assays were performed to explore the role of METTL14 in lung cancer progression in vitro...
May 10, 2024: World Journal of Surgical Oncology
https://read.qxmd.com/read/38724705/single-cell-transcriptomic-analyses-reveal-distinct-immune-cell-contributions-to-epithelial-barrier-dysfunction-in-checkpoint-inhibitor-colitis
#30
JOURNAL ARTICLE
Molly Fisher Thomas, Kamil Slowikowski, Kasidet Manakongtreecheep, Pritha Sen, Nandini Samanta, Jessica Tantivit, Mazen Nasrallah, Leyre Zubiri, Neal P Smith, Alice Tirard, Swetha Ramesh, Benjamin Y Arnold, Linda T Nieman, Jonathan H Chen, Thomas Eisenhaure, Karin Pelka, Yuhui Song, Katherine H Xu, Vjola Jorgji, Christopher J Pinto, Tatyana Sharova, Rachel Glasser, PuiYee Chan, Ryan J Sullivan, Hamed Khalili, Dejan Juric, Genevieve M Boland, Michael Dougan, Nir Hacohen, Bo Li, Kerry L Reynolds, Alexandra-Chloé Villani
Immune checkpoint inhibitor (ICI) therapy has revolutionized oncology, but treatments are limited by immune-related adverse events, including checkpoint inhibitor colitis (irColitis). Little is understood about the pathogenic mechanisms driving irColitis, which does not readily occur in model organisms, such as mice. To define molecular drivers of irColitis, we used single-cell multi-omics to profile approximately 300,000 cells from the colon mucosa and blood of 13 patients with cancer who developed irColitis (nine on anti-PD-1 or anti-CTLA-4 monotherapy and four on dual ICI therapy; most patients had skin or lung cancer), eight controls on ICI therapy and eight healthy controls...
May 9, 2024: Nature Medicine
https://read.qxmd.com/read/38724673/aml-t-cell-interactomics-uncover-correlates-of-patient-outcomes-and-the-key-role-of-icam1-in-t-cell-killing-of-aml
#31
JOURNAL ARTICLE
Ece Canan Sayitoglu, Bogdan A Luca, Allison Paige Boss, Benjamin Craig Thomas, Robert Arthur Freeborn, Molly Javier Uyeda, Pauline Ping Chen, Yusuke Nakauchi, Colin Waichler, Norman Lacayo, Rosa Bacchetta, Ravindra Majeti, Andrew J Gentles, Alma-Martina Cepika, Maria Grazia Roncarolo
T cells are important for the control of acute myeloid leukemia (AML), a common and often deadly malignancy. We observed that some AML patient samples are resistant to killing by human-engineered cytotoxic CD4+ T cells. Single-cell RNA-seq of primary AML samples and CD4+ T cells before and after their interaction uncovered transcriptional programs that correlate with AML sensitivity or resistance to CD4+ T cell killing. Resistance-associated AML programs were enriched in AML patients with poor survival, and killing-resistant AML cells did not engage T cells in vitro...
May 9, 2024: Leukemia
https://read.qxmd.com/read/38724656/dnt-cells-mediate-resistance-to-car-t-cells-therapy-in-a-pediatric-patient-with-relapsed-and-refractory-b-all
#32
JOURNAL ARTICLE
Ruotong Chen, Qianshan Tao, Fan Wu, Zhimin Zhai, Yuchen Jiang, Caixian Xu, Huiping Wang
Chimeric antigen receptor T (CAR-T) cells therapy is a milestone achievement in the immunotherapy of relapsed and refractory (R/R) B cell acute lymphoblastic leukemia (B-ALL). However, some patients treated with CAR-T cells do not achieve complete remission, the mechanisms of which have not been elucidated. In the present study, we report a 9-year-old pediatric patient with refractory B-ALL received a triple infusion of autologous CD19 CAR-T cells therapy after the second relapse. CAR-T cells expanded in the peripheral blood and bone marrow...
May 10, 2024: Annals of Hematology
https://read.qxmd.com/read/38724527/chiral-coordination-polymer-nanowires-boost-radiation-induced-in-situ-tumor-vaccination
#33
JOURNAL ARTICLE
Zhusheng Huang, Rong Gu, Shiqian Huang, Qian Chen, Jing Yan, Xiaoya Cui, Haojie Jiang, Dan Yao, Chuang Shen, Jiayue Su, Tao Liu, Jinhui Wu, Zhimin Luo, Yiqiao Hu, Ahu Yuan
Radiation-induced in situ tumor vaccination alone is very weak and insufficient to elicit robust antitumor immune responses. In this work, we address this issue by developing chiral vidarabine monophosphate-gadolinium nanowires (aAGd-NWs) through coordination-driven self-assembly. We elucidate the mechanism of aAGd-NW assembly and characterize their distinct features, which include a negative surface charge, ultrafine topography, and right-handed chirality. Additionally, aAGd-NWs not only enhance X-ray deposition but also inhibit DNA repair, thereby enhancing radiation-induced in situ vaccination...
May 9, 2024: Nature Communications
https://read.qxmd.com/read/38724195/human-t-cell-activation-with-toxoplasma-gondii-antigens-loaded-in-maltodextrin-nanoparticles
#34
JOURNAL ARTICLE
Laura García-López, Alejandro Zamora-Vélez, Mónica Vargas-Montes, Juan Camilo Sanchez-Arcila, François Fasquelle, Didier Betbeder, Jorge Enrique Gómez-Marín
Toxoplasmosis is the most prevalent parasitic zoonosis worldwide, causing ocular and neurological diseases. No vaccine has been approved for human use. We evaluated the response of peripheral blood mononuclear cells (PBMCs) to a novel construct of Toxoplasma gondii total antigen in maltodextrin nanoparticles (NP/TE) in individuals with varying infectious statuses (uninfected, chronic asymptomatic, or ocular toxoplasmosis). We analyzed the concentration of IFN-γ after NP/TE ex vivo stimulation using ELISA and the immunophenotypes of CD4+ and CD8+ cell populations using flow cytometry...
July 2024: Life Science Alliance
https://read.qxmd.com/read/38723671/boosting-humoral-and-cellular-immunity-with-enhanced-sting-activation-by-hierarchical-mesoporous-metal-organic-framework-adjuvants
#35
JOURNAL ARTICLE
Chengjie Huang, Xiao Zhi, Tianbao Ye, Xiuyuan Wang, Ke Li, Yiyang Li, Qiang Zhang, Lai Jiang, Xianting Ding
Vaccination is essential for preventing and controlling infectious diseases, along with reducing mortality. Developing safe and versatile adjuvants to enhance humoral and cellular immune responses to vaccines remains a key challenge in vaccine development. Here, we designed hierarchical mesoporous MOF-801 (HM801) using a Cocamidopropyl betaine (CAPB) and a Pluronics F127 in an aqueous phase system. Meanwhile, we synthesized a novel SARS-CoV-2 nanovaccine (R@M@HM801) with a high loading capacity for both the STING agonist (MSA-2) and the Delta receptor binding domain (Delta-RBD) antigen...
May 7, 2024: Journal of Controlled Release
https://read.qxmd.com/read/38723627/circadian-tumor-infiltration-and-function-of-cd8-t%C3%A2-cells-dictate-immunotherapy-efficacy
#36
JOURNAL ARTICLE
Chen Wang, Qun Zeng, Zeynep Melis Gül, Sisi Wang, Robert Pick, Phil Cheng, Ruben Bill, Yan Wu, Stefan Naulaerts, Coline Barnoud, Pei-Chun Hsueh, Sofie Hedlund Moller, Mara Cenerenti, Mengzhu Sun, Ziyang Su, Stéphane Jemelin, Volodymyr Petrenko, Charna Dibner, Stéphanie Hugues, Camilla Jandus, Zhongwu Li, Olivier Michielin, Ping-Chih Ho, Abhishek D Garg, Federico Simonetta, Mikaël J Pittet, Christoph Scheiermann
The quality and quantity of tumor-infiltrating lymphocytes, particularly CD8+ T cells, are important parameters for the control of tumor growth and response to immunotherapy. Here, we show in murine and human cancers that these parameters exhibit circadian oscillations, driven by both the endogenous circadian clock of leukocytes and rhythmic leukocyte infiltration, which depends on the circadian clock of endothelial cells in the tumor microenvironment. To harness these rhythms therapeutically, we demonstrate that efficacy of chimeric antigen receptor T cell therapy and immune checkpoint blockade can be improved by adjusting the time of treatment during the day...
May 2, 2024: Cell
https://read.qxmd.com/read/38723624/chemoradiotherapy-induced-ackr2-tumor-cells-drive-cd8-t%C3%A2-cell-senescence-and-cervical-cancer-recurrence
#37
JOURNAL ARTICLE
Dongfang Dai, Yifei Pei, Biqing Zhu, Deqiang Wang, Siyu Pei, Huan Huang, Qingchen Zhu, Xiuyu Deng, Jialin Ye, Jing Xu, Xiaoxiang Chen, Mingzhu Huang, Yichuan Xiao
Tumor recurrence after chemoradiotherapy is challenging to overcome, and approaches to predict the recurrence remain elusive. Here, human cervical cancer tissues before and after concurrent chemoradiotherapy (CCRT) analyzed by single-cell RNA sequencing reveal that CCRT specifically promotes CD8+ T cell senescence, driven by atypical chemokine receptor 2 (ACKR2)+ CCRT-resistant tumor cells. Mechanistically, ACKR2 expression is increased in response to CCRT and is also upregulated through the ligation of CC chemokines that are produced by activated myeloid and T cells...
April 30, 2024: Cell reports medicine
https://read.qxmd.com/read/38723599/one-size-might-fit-all-indole-3-propionic-acid-potentiates-pan-cancer-immunotherapy
#38
JOURNAL ARTICLE
Zheshun Pi, Weici Liu, Wenjun Mao
Microbial-based therapies have the potential to combat immunotherapy resistance, extending the boundaries of oncological therapeutics. In a recent issue of Cell, Jia et al. demonstrates an example of microbial collaboration to produce a postbiotic that promotes the stemness program of CD8+ T cells to augment immunotherapy at the pan-cancer level.
May 8, 2024: Cell Host & Microbe
https://read.qxmd.com/read/38723578/immune-dysregulation-in-chronic-inflammatory-demyelinating-polyneuropathy
#39
JOURNAL ARTICLE
Yingkai Li, John S Yi, Jeffrey T Guptill, Vern C Juel, Lisa Hobson-Webb, Shruti M Raja, Tabitha Karatz, Karissa L Gable
OBJECTIVE: Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune disorder of the peripheral nerves with an incompletely understood underlying pathophysiology. This investigation focused on defining B and T cell frequencies, T cell functional capacity and innate immune system analysis in patients with CIDP. METHODS: By using multi-parameter flow cytometry, we examined the phenotype and function of PBMCs in 25 CIDP patients who were relatively clinically stable on treatment who met EFNS/PNS criteria, 21 patients with genetically confirmed hereditary neuropathy and 25 healthy controls...
May 5, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38723554/mda5-autoimmunity-and-interstitial-pneumonitis-contemporaneous-with-the-covid-19-pandemic-mip-c
#40
JOURNAL ARTICLE
Paula David, Saptarshi Sinha, Khizer Iqbal, Gabriele De Marco, Sahar Taheri, Ella McLaren, Sheetal Maisuria, Gururaj Arumugakani, Zoe Ash, Catrin Buckley, Lauren Coles, Chamila Hettiarachchi, Emma Payne, Sinisa Savic, Gayle Smithson, Maria Slade, Rahul Shah, Helena Marzo-Ortega, Mansoor Keen, Catherine Lawson, Joanna Mclorinan, Sharmin Nizam, Hanu Reddy, Omer Sharif, Shabina Sultan, Gui Tran, Mark Wood, Samuel Wood, Pradipta Ghosh, Dennis McGonagle
BACKGROUND: Anti-MDA5 (Melanoma differentiation-associated protein-5) positive dermatomyositis (MDA5+ -DM) is characterised by rapidly progressive interstitial lung disease (ILD) and high mortality. MDA5 is an RNA sensor and a key pattern recognition receptor for the SARS-CoV-2 virus. METHODS: This is a retrospective observational study of a surge in MDA5 autoimmunity, as determined using a 15 muscle-specific autoantibodies (MSAs) panel, between Janurary 2018 and December 2022 in Yorkshire, UK...
May 8, 2024: EBioMedicine
keyword
keyword
116855
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.